MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2025 International Congress

    Oxidative stress in Progressive Supranuclear Palsy

    P. Alster, D. Otto-ślusarczyk, M. Struga, N. Madetko-Alster (Warsaw, Poland)

    Objective: The goal of the study is to evaluate the significance of oxidative stress in the examination and pathophysiology of Progressive Supranuclear Palsy (PSP). Additionally,…
  • 2025 International Congress

    The Global Parkinson’s Genetics Program: Expanding the Diversity of Neurological Disorder Data: 2025 Update

    GP2. Parkinson'S_genetics_program (Chevy Chase, USA)

    Objective: To broaden the available data for Parkinson's Disease (PD) and related disorders by integrating genetic data from more than 115,000 participants worldwide through genotyping…
  • 2025 International Congress

    Disease Characteristics of the First 100 Participants in the CurePSP Genetics Program Cohort

    C. Obasi, V. Zhao, C. Martinez, S. Scholz, H. Morris, N. Mcfarland, M. Nance, J. Wang, N. Mencacci, B. Cuoto, T. Foroud, J. Verbrugge, A. Miller, L. Heathers, L. Honig, A. Lang, F. Rodriguez-Porcel, P. Moretti, M. Mesaros, J. Brummet, K. Diaz, A. Wills (Boston, USA)

    Objective: To increase our understanding of the pathogenesis of atypical parkinsonian disorders though genetics, and to build a cohort of individuals for future research. Background:…
  • 2025 International Congress

    Case report and Literature Review on Atypical Parkinson’s Disease

    MJ. Dashdorj (Ulaanbaatar, Mongolia)

    Objective: Atypical parkinsonism is classified as a subgroup of Progressive neurodegenerative diseases, characterized by symptoms of Parkinson's disease. Background: Progressive supra nuclear palsy of the…
  • 2025 International Congress

    Multiscale entropy: a New Oculomotor Measure of PSP.

    C. O'Keeffe, A. Gallagher, J. Inocentes, B. Coe, B. White, D. Brien, D. Munoz, R. Walsh, T. Lynch, C. Fearon (Dublin, Ireland)

    Objective: The objective of this study was investigate whether multiscale entropy, a measure of complexity, when applied to the path of unconstrained eye movements could…
  • 2025 International Congress

    Spatial Metabolic Covariance Networks in PSP: Implications for Symptomatology and their Neural Basis

    B. Wang, W. Luo (Hangzhou, China)

    Objective: This study aimed to apply spatial ICA to 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) data from PSP patients and healthy controls (HCs) to identify…
  • 2025 International Congress

    Atypical Parkinsonism in the Setting of Normal Pressure Hydrocephalus and a Colloid Cyst: Diagnostic Challenge

    QB. Nguyen, O. Los (Oklahoma City, USA)

    Objective: To present a case of atypical parkinsonism likely secondary to normal pressure hydrocephalus (NPH) and a colloid cyst at the foramen of Monro. Background:…
  • 2025 International Congress

    Tracking Progression and Survival in a Large Cohort of Patients with Progressive Supranuclear Palsy

    DP. Vaughan, R. Real, RG. Fumi, M. Theilmann Jensen, T. Revesz, Z. Jaunmuktane, T. Warner, A. Church, P. Leigh, E. Jabbari, H. Zetterberg, AJ. Heslegrave, E. Veleva, O. Swann, B. Ghosh, M. Hu, C. Kobylecki, P. Study Group, J. Rohrer, JB. Rowe, HR. Morris (London, United Kingdom)

    Objective: To characterise a longitudinal cohort of patients with Progressive Supranuclear Palsy (PSP) and identify factors influencing progression. Background: Median survival in PSP is approximately…
  • 2025 International Congress

    Unraveling the Genetic Architecture of Progressive Supranuclear Palsy in East Asians

    P. Chen, R. Lin, N. Lee, J. Hsu, C. Tai, R. Wu, H. Chiang, Y. Wu, C. Lu, H. Chang, T. Lee, Y. Chang, C. Lin (Taipei, Taiwan)

    Objective: We aim to elucidate the genetic architecture of progressive supranuclear palsy (PSP) in East Asians through whole-exome sequencing in a multi-center study in Taiwan.…
  • 2025 International Congress

    Parkinsonism in Uzbekistan: Clinical and Demographic Insights from 2024

    Y. Nishonova, B. Mukhammedaminov, L. Kenjaeva, N. Aripova (Tashkent, Uzbekistan)

    Objective: We retrospectively analyzed the medical records of all parkinsonism patients admitted to our clinic in 2024, examining neurological, psychiatric, radiological, and demographic characteristics of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley